Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure
NCT: NCT07057323 · ENROLLING_BY_INVITATION
Brief Summary
The purpose of this study is to evaluate the efficacy of CS Reducer implantation in patients with HFpEF and CMD on left ventricular filling pressures, specifically invasive measurement of PAWP during standardized exercise.
Frequently Asked Questions
What is Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure?
Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure is a clinical trial registered under NCT07057323. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT07057323?
The current status of NCT07057323 (Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure) is: ENROLLING_BY_INVITATION.
When did Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure start?
Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure started on 2025-10-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.